Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2025-07-31 Interim / Quarterly Rep…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB_Half-Year_2025_Report-FR-FINAL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport de gestion du premier semestre 2025' (Management Report for the first half of 2025). It contains detailed financial performance metrics, consolidated financial statements, cash flow tables, and financial forecasts. Since it covers a period shorter than a full fiscal year (first half) and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H1 2025
2025-07-31 French
UCB_Half-Year_2025_Report-NL-FINAL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halfjaarlijks Financieel Verslag 2025' (Half-Yearly Financial Report 2025) for UCB NV, covering the period ending June 30, 2025. It contains comprehensive financial statements, including a consolidated balance sheet, cash flow statement, and detailed notes to the financial statements, as well as an auditor's review report. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-07-31 Dutch
EN FMR 10.07.2025.pdf
Major Shareholding Notification Classification · 99% confidence The document is a 'Transparency notification' issued by UCB SA/NV, announcing that FMR LLC's holding crossed downwards a 5% threshold following a disposal of shares. This type of filing, which reports changes in significant share ownership levels by an entity or person, directly corresponds to the definition of a Major Shareholding Notification. The specific reference to 'law of 2 May 2007 on the disclosure of large shareholdings' confirms this regulatory context. Therefore, the appropriate code is MRQ.
2025-07-10 English
FR FMR 10.07.2025.pdf
Director's Dealing Classification · 98% confidence The document is a 'Notification de transparence' (Transparency Notification) issued by FMR LLC concerning a change in its shareholding in UCB SA. It explicitly details the crossing of a threshold (5%) related to voting rights ('droits de vote') on a specific date (July 3, 2025). This type of filing, which reports changes in significant share ownership levels by individuals or entities, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is the most specific category available for this content.
2025-07-10 French
NL FMR 10.07.2025.pdf
Major Shareholding Notification Classification · 99% confidence The document is titled "Transparantieverklaring FMR LLC" (Transparency Declaration FMR LLC) and explicitly states it is based on Article 14 of the law regarding the disclosure of major shareholdings. It details a change in shareholding percentage by FMR LLC, crossing below the 5% threshold on July 3, 2025. This content directly relates to reporting changes in significant share ownership, which corresponds to the Major Shareholding Notification category (MRQ). Although it is a formal declaration, the core subject matter is the change in major shareholding, not a general regulatory filing (RNS) or a director's dealing (DIRS).
2025-07-10 Dutch
EN Transparency BR.pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Transparency notification' from UCB SA/NV announcing that it received a notification from BlackRock, Inc. regarding a change in its shareholding in UCB. Specifically, it details the acquisition of voting rights, crossing the 5% threshold, and lists the entities involved and the resulting share counts as of July 1, 2025. This content directly relates to changes in significant share ownership levels, which corresponds to the Major Shareholding Notification (MRQ) definition. It is not an earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific insider/major shareholder transaction disclosure.
2025-07-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.